Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04463004
Brief Title: Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation

First Submitted : July 7, 2020
First Submitted that Met QC Criteria : July 7, 2020
First Posted : July 9, 2020

Last Update Submitted that Met QC Criteria : February 16, 2021
Last Update Posted : February 17, 2021